ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway

Liu, Ying; Yang, Changmou; Chen, Shisheng; Liu, Weihao; Liang, Jingyi; He, Shuhua*; Hui, Jialiang*南方医科大学; 中山大学
Cancer Gene Therapy2023-3DOI: 10.1038/s41417-022-00563-1
5被引10阅读
引用收藏
分享

摘要

Bone metastasis is the most common complication responsible for most deaths in the advanced stages of prostate cancer (PCa). However, the exact mechanism of bone metastasis in PCa remains unelucidated. Herein, we explored the function and potential underlying mechanism of exosomal miR-375 in bone metastasis and tumor progression in PCa. This study revealed that miR-375 expression was markedly upregulated in advanced PCa with bone metastasis and metastatic PCa cell lines. Moreover, miR-375 showed high expression in PCa-derived exosomes and could be delivered to human mesenchymal stem cells (hMSCs) via exosomes. Mechanistically, miR-375 directly targeted DIP2C and upregulated the Wnt signaling pathway, thereby promoting osteoblastic differentiation in hMSCs. Furthermore, miR-375 promoted the proliferation, invasion, and migration of PCa cells in vitro and enhanced tumor progression and osteoblastic metastasis in vivo. Notably, the expression of miR-375, TCF-1, LEF-1, and beta-catenin in was higher in PCa tissues with bone metastasis than in PCa tissues without bone metastasis and showed a continuous increase, whereas DIP2C, cyclin D1, and Axin2 showed an opposite expression pattern. In conclusion, our study suggests that cancer-derived exosomal miR-375 targets DIP2C, activates the Wnt signaling pathway, and promotes osteoblastic metastasis and PCa progression.

学科与关键词

关键词
GENE-EXPRESSIONBREAST-CANCERCELLSBIOMARKERSDIFFERENTIATIONMICRORNA-375CARCINOMASACTIVATORRECEPTORMIRNAS
相关
加载中…
  • Exosomal miR-1275 Secreted by Prostate Cancer Cells Modulates Osteoblast Proliferation and Activity by Targeting the SIRT2/RUNX2 Cascade
    Zou, Zihao*; Dai, Ranran; Deng, Nan; Su, Wei; Liu, PingCell Transplantation, 2021, 30: 09636897211052977.被引 6
  • MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
    Gan, Junqing; Liu, Shan; Zhang, Yu; He, Liangzi; Bai, Lu; Liao, Ran; Zhao, Juan; Guo, Madi; Jiang, Wei; Li, Jiade; Li, Qi; Mu, Guannan; Wu, Yangjiazi; Wang, Xinling; Zhang, Xingli; Zhou, Dan; Lv, Huimin; Wang, Zhengfeng; Zhang, Yanqiao; Qian, Cheng; Feng, MeiYan; Chen, Hui; Meng, Qingwei; Huang, Xiaoyi*Experimental and Molecular Medicine, 2022, 54(8): 1290-1305.被引 16
  • Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K/AKT/mTOR pathway
    Tian, Gaoqiang; Hu, Konghe; Qiu, Sujun; Xie, Yingming; Cao, Yanlin; Ni, Songjia*; Zhang, Lifang*Experimental and Therapeutic Medicine, 2021, 22(5): 1304.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Gene Therapy
发表日期
2023-03
卷期
第 30 卷, 第 3 期
页码
437-449
DOI
10.1038/s41417-022-00563-1
语言
ENGLISH
成果收录
SCIE
资助标注
President Foundation of Nanfang Hospital, Southern Medical University [2020B025]

作者

  • L

    Liu, Ying (第一作者)

    southern med univ

  • Y

    Yang, Changmou

    southern med univ · sun yat sen univ

查看全部 7 位作者收起作者
  • C

    Chen, Shisheng

    southern med univ

  • L

    Liu, Weihao

    southern med univ

  • L

    Liang, Jingyi

    southern med univ

  • H

    He, Shuhua (通讯)

    southern med univ

  • H

    Hui, Jialiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417